A Regulatory Moat Is an Asset Class

A regulatory moat is the durable advantage a company earns by being able to prove, not merely assert, that its product satisfies the rules a buyer is legally bound to follow. In Europe's regulated sectors — banking, healthcare, defence, public administration — compliance, confidentiality and data residency are not overhead. They are the product, and they are an investable edge.

What is a regulatory moat, and why does it count as an asset?

Most moats are familiar: network effects, switching costs, brand, scale economies, proprietary data. A regulatory moat is the quieter cousin. It is the advantage that accrues to a company when the law makes it expensive, slow or impossible for a buyer to choose a non-compliant alternative — and when satisfying that law natively, rather than bolting it on, is genuinely hard.

The instinct in Silicon Valley is to read regulation as friction: a tax on innovation, a thing to be lobbied away or routed around. That reading is not wrong everywhere. But it inverts the truth in the markets that matter most for European deeptech. For a bank, a hospital, a defence ministry or a public administration, the question is never “is this product clever?” It is “can I deploy this without breaching the law, and can I demonstrate that to my regulator?” In those markets, provable compliance is the specification. A vendor who cannot meet it is not a cheaper option; it is not an option at all.

That is why a regulatory moat behaves like an asset. It is built with sunk effort — legal architecture, audited controls, certifications, data-residency guarantees, cryptographic design — that a competitor cannot replicate quickly or cheaply. It compounds: each certification, each regulated reference customer, each year of clean operation raises the bar for the next entrant. And it is defensible against exactly the players who would otherwise win on capital and scale, because the deepest pockets in the world cannot buy a shortcut through a jurisdiction's rulebook. At Pyratz Corp. we operate at the intersection of deeptech, regulatory moat and capital markets precisely because we think this third term is underpriced.

Is compliance a competitive advantage or a cost?

Both — and which one it is depends entirely on whether you treat the rules as the enemy or the brief.

Consider the raw stakes, because they end the “regulation is just a cost” argument. Under the EU AI Act, the top tier of fines for prohibited practices reaches €35 million or 7% of total worldwide annual turnover, whichever is higher; breaches of the obligations on high-risk systems run to €15 million or 3% of turnover. Under the GDPR, the ceiling is €20 million or 4% of global turnover, and cumulative fines since the regulation took effect now stand in the billions — with a single €1.2 billion penalty levied on Meta by the Irish Data Protection Commission in 2023.

Read those numbers from the buyer's chair, not the vendor's. A regulated institution that adopts a tool which later proves non-compliant does not merely lose a feature; it inherits a balance-sheet liability and a reportable incident. Compliance is therefore not a line item the buyer would prefer to skip — it is a risk they are paying to extinguish. The vendor who can extinguish it provably is selling the most valuable thing in the room. Compliance is a cost to the firm that bolts it on at the end and an advantage to the firm that builds it in from the first commit. The same fact, opposite signs, decided by architecture.

The Brussels Effect, turned into go-to-market

The strategic frame for all of this is the Brussels Effect — the political scientist Anu Bradford's argument that the EU exports its standards to the world through the gravity of its single market, because multinationals find it cheaper to adopt the strictest applicable rule globally than to maintain two product lines. GDPR is the canonical case: a European regulation that quietly rewrote privacy defaults from California to São Paulo.

The usual telling of the Brussels Effect is defensive — Europe regulates, the world complies, and that is the extent of European power. We think that reading stops one move too early. As we argued in Asymmetric Innovation, the AI Act and GDPR, routinely cast as handicaps, are a leverage point: for banks, hospitals, defence ministries and public administrations, data residency and provable compliance are not friction — they are the product. This is the Brussels Effect turned into a go-to-market. The jurisdiction that writes the rules is uniquely placed to build, and sell, the only stack that natively satisfies them.

This is judo, not sumo. A European company cannot out-spend a US hyperscaler on compute or capital. It can, however, choose to fight on the one dimension where the incumbent's scale is a liability rather than an advantage: a product built around a rulebook the incumbent treats as an inconvenience, sold to buyers for whom that rulebook is binding law. The asymmetry is real, and it is structural.

Where the moat is deepest: regulated demand, by sector

Banks and asset managers face demands for data residency, auditability, MiFID/UCITS controls and confidentiality of positions and flows — a regulator must be able to inspect, and a competitor cannot deploy a position book to a non-compliant cloud. Hospitals and health systems must satisfy GDPR special-category data rules, patient confidentiality and in-jurisdiction processing, since patient data cannot legally leave the perimeter and “good enough” is a breach. Defence and sovereign bodies require sovereignty of supply, no foreign-jurisdiction exposure and classified-data handling; a foreign-controlled stack is disqualified by mandate, not by price. Public administration must meet procurement rules, citizen-data protection and transparency obligations, and compliance is written into the tender so non-compliant bids are not scored.

The pattern across every row is the same. The advantage is not that the European product is faster or cheaper. It is that the buyer is legally prevented from choosing the alternative — and that the compliant alternative is hard to build. That second clause matters. A moat that any competitor can ford in a quarter is no moat. The defensibility comes from the difficulty of building provable compliance into the substrate of the product.

What makes the moat unbridgeable: confidentiality by construction

The strongest version of a regulatory moat is the one where the technology itself enforces the rule, so compliance is not a policy you trust but a property you can prove. This is why we are drawn to confidential-computing approaches, and specifically to fully homomorphic encryption (FHE) — computation performed directly on encrypted data, so that information can be processed without ever being decrypted, and therefore without ever being exposed.

It is not a coincidence that Zama, the FHE specialist and a French unicorn, sits in the Pyratz portfolio. FHE collapses the oldest trade-off in regulated software — the choice between using data and protecting it. For a bank that must keep positions confidential, a hospital that must never expose patient records, or a fund that wants the auditability of public infrastructure without broadcasting its book, encryption-in-use is the difference between “trust our controls” and “the data was mathematically never readable.” That is the deepest kind of compliance: not asserted, but provable; not promised, but structural.

The same logic runs through the confidential-finance direction we have backed. Zaïfer, a Zama × PyratzLabs joint venture for confidential and compliant on-chain finance (reported by DL News), was an early expression of exactly this thesis: bring confidentiality to on-chain finance, so that tokenised assets can carry the transparency and settlement guarantees of public infrastructure without surrendering the secrecy that regulated participants are obliged to keep. It points squarely at where we intend to go next — a regulated fintech built around confidential, tokenised funds, tied to our planned asset-management activity and the UCITS licence on our financial calendar.

How do you invest in a regulatory moat?

You invest in it the way you invest in any durable advantage: by underwriting defensibility, not just growth. Three tests separate a real regulatory moat from compliance theatre.

First, is the rule binding on the buyer, with teeth? A market governed by fines measured in points of global turnover — as the AI Act and GDPR now are — is a market where compliance is a board-level priority, not a nice-to-have. Second, is compliance hard to provide, and built in rather than bolted on? The moat is only as deep as the difficulty of replicating it; cryptographic and architectural guarantees beat policy documents. Third, does the advantage compound? Certifications, regulated reference customers and clean operating history are assets that accumulate and raise the entry bar for the next firm.

This is the operating logic behind our model and the reason we list. A venture builder that embeds operators, rather than only writing cheques, is well placed to do the unglamorous work a regulatory moat demands — the audits, the certifications, the cryptographic design — inside the companies it backs. And a European public-markets vehicle is the natural place to hold assets whose edge is sovereignty itself.

Frequently asked questions

What is a regulatory moat in deeptech?

A regulatory moat is the durable competitive advantage a deeptech company gains when the law requires its buyers to use compliant technology, and when satisfying that law natively is difficult and costly to replicate. In regulated sectors such as banking, healthcare and defence, provable compliance, confidentiality and data residency become the core of the product rather than overhead, which makes the advantage both defensible and investable.

Is compliance a competitive advantage or just a cost?

It is both, and the difference is architectural. For a firm that adds compliance at the end, it is a cost. For a firm that builds it into the product from the start, it is an advantage, because regulated buyers face fines of up to 7% of global turnover under the EU AI Act and 4% under the GDPR, and will pay for a vendor who provably removes that liability rather than one who merely claims to.

What is the Brussels Effect and how does it apply to AI and data?

The Brussels Effect, a term coined by Anu Bradford, describes how the EU exports its regulatory standards globally because the size of its single market makes the strictest applicable rule the de facto world standard. Applied to AI and data, it means the AI Act and GDPR shape products well beyond Europe — and that European companies are uniquely placed to build and sell stacks that natively satisfy those rules.

How does fully homomorphic encryption strengthen a regulatory moat?

Fully homomorphic encryption (FHE) allows computation on encrypted data without decrypting it, so confidentiality is enforced by mathematics rather than by trust in a vendor's controls. This turns compliance from a claim into a provable property, which is the strongest form of regulatory moat — especially in banking, healthcare and confidential on-chain finance.

Which sectors offer the deepest regulatory moats?

The deepest moats are in sectors where the law disqualifies non-compliant vendors outright: banking and asset management, hospitals and health systems, defence and sovereign bodies, and public administration. In each, data residency, confidentiality and auditability are legal requirements, so a compliant European stack competes against a smaller field — or none at all.

To follow how this thesis turns into capital and companies, read the related vision piece Sovereign by design, see our portfolio, or follow our investor-relations updates.

This is not investment advice. Pyratz Corp. (MLPTZ · ISIN FR0013371507) is listed on Euronext Access Paris; trading resumed following the reverse takeover approved on 29 June 2026, and the shares are tradable on Euronext Access Paris. Nothing here is a recommendation to buy or sell any security or a promise of returns.